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167 Epidemic outbreak of Burkholderia cepacia in a reference center
of cystic ﬁbrosis in Buenos Aires, Argentina
G. Diez1, V. D’Alessandro1, F. Renterı´a1, C. Varas1, E. Segal1. 1Pulmonary,
Children’s Hospital La Plata, La Plata, Buenos Aires, Argentina
Introduction: The prevalence of Burkholderia cepacia complex (BCC) has in-
creased in many centers of the world. Infection control is one of the main tools for
prevention.
Objective: To describe strategies adopted in an epidemic outbreak of BCC.
Materials and Methods: Descriptive analysis. We review clinical histories from
January 2004 to July 2007 of 248 patients (pts) with Cystic Fibrosis (CF) assisted
in our Center.
Results: BCC were isolated in 64 pts (35 in 2004, 19 in 2005, 9 in 2006 and 1 in
2007). It was isolated in only one opportunity in 36 pts, twice in 19 and three
or more times in 9. Of the 64 pts, 46 continue in follow-up, and eight of them
died, none of cepacia syndrome or of worsening attributed to BCC. The genotype
analysis made in 19 children in an international laboratory of reference conﬁrmed
BCC in 17 with the same strain and in 2 Delftia tsuruhatensis. After the BCC’s
ﬁrst isolations we intensiﬁed infection control policies already established. During
2005 and 2006 the concurrence of patients to the Center was suspended, and the
professionals of the team went to the patients’ homes and other hospitals of the
state of Buenos Aires for their assistance. In 2007 the decentralization was kept on
5 areas of assistance (4 far from the hospital) according bacteriology. The incidence
experienced a signiﬁcant decrease.
Conclusion: The segregation of children with BCC and the infection control
policies are standardized and their beneﬁts have been demonstrated. The efforts of
the professional team must be recognized. The psychological impact which patients
experience is an important obstacle that should be minimized.
168* Invasion of Burkholderia cepacia complex isolates into
lung epithelial cells involves glycolipid receptors
T. Mullen1, M. Callaghan1, S. McClean1. 1Centre of Microbial Host Interactions,
Institute of Technology Tallaght Dublin, Dublin, Ireland
B. cepacia is a Gram-negative bacteria comprising at least nine species and
collectively referred to as the B. cepacia complex (Bcc). Although the prevalence
of this opportunistic pathogen has declined due to stringent isolation procedures,
when it does colonise an individual with cystic ﬁbrosis, it remains a major cause
of morbidity and mortality. B. cenocepacia and B. multivorans are the most
virulent and clinically relevant species. One of the mechanisms of pathogenesis
of Bcc is invasion of lung epithelial cells, with the two most virulent species
invading most readily. Prior to invasion, these bacteria need to bind to the lung
epithelial cells. Previously, it has been shown that Bcc bind to many glycolipid
receptors, including gangliosides and globosides, on lung epithelia. We have now
demonstrated that these glycolipid receptors are essential for invasion. Enzyme
treatment to remove galactose moieties from the lung cell surface dramatically
inhibited invasion, while removal of sialic acid did not. In addition, treatment of lung
cells with sphingolipid biosynthetic pathway inhibitors at non-cytotoxic levels also
signiﬁcantly reduced invasion by Bcc strains. In contrast, results obtained following
treatment with N-acetylcysteine, indicated that mucus did not play a major role in
the invasion process. Using labelled bacteria, we found that different strains within
Bcc showed different preferential binding to particular glycosphingolipids. We are
now evaluating a series of novel glycoconjugate molecules for their ability to inhibit
bacterial binding and invasion and thereby reduce both colonisation and virulence
potential of this difﬁcult CF pathogen.
Supported by: PRTLI as administered by HEA, Ireland.
169 Degradation of host defence molecules by CF-related pathogens
grown as bioﬁlms
G.G. Einarsson1, S.L. Martin1, B. Walker1, J.S. Elborn2, A. McDowell2. 1School
of Pharmacy, Queen’s University Belfast, Belfast, United Kingdom; 2School of
Medicine and Dentistry, Queen’s University Belfast, Belfast, United Kingdom
We investigated the ability of secreted bacterial proteinases from three pathogens
[Burkholderia multivorans (Bm), Burkholderia cenocepacia (Bc), and Pseudomonas
aeruginosa (Pa)] involved in chronic bacterial infections in cystic ﬁbrosis to degrade
various host defence-related molecules. These included two endogenous proteinase
inhibitors, secretory leukocyte proteinase inhibitor (rhSLPI) and alpha-1 antitrypsin
(AAT); two relevant immunoglobulins, secretory IgA (sIgA) and IgG, and two
proteins important in innate immunity, lactoferrin and lysozyme.
Host defence-related molecules were co-incubated with cell-free supernatants from
48 hour bioﬁlm cultures, grown on mucin-coated microplates, from all three
pathogens under investigation (six isolates from each species). No degradation of
AAT, sIgA, IgG, and lactoferrin was observed for any of the organisms. Of the
18 isolates tested, only one demonstrated the ability to degrade lysozyme. This
was an environmental isolate of Pa which was included as a comparison for the
predominantly clinically relevant isolates used in the study.
In contrast, all isolates of Bm (n = 4) and Pa (n = 4) were able to degrade rhSLPI
however, out of ﬁve bacterial isolates tested for Bc only two demonstrated a limited
ability to degrade the molecule with >95% of the protein band still remaining intact
at the end of the experiment.
This study demonstrates that the majority of the host defence molecules investigated
are resistant to degradation by bacterial proteinases from Bm, Bc and Pa when
grown as a bioﬁlm. However, rhSLPI was vulnerable to signiﬁcant degradation
which could result in aberrant serine proteolysis in regions of the lungs containing
bioﬁlm growth.
170 Cross-infection by Staphylococcus aureus among
cystic ﬁbrosis patients
L. Pereira1, C. Silva-Costa2, F. Pinto2, C. Barreto1, M. Ramirez2, J. Melo-
Cristino2. 1Cystic Fibrosis Centre, Hospital Santa Maria, Lisbon, Portugal;
2Microbiology Dep., Hospital Santa Maria, Lisbon, Portugal
Chronic infection and progressive pulmonary destruction, in Cystic Fibrosis (CF)
patients, are mainly caused by Pseudomonas aeruginosa and Staphylococcus aureus.
S. aureus is generally the ﬁrst infectious agent. These infections may be acquired
from people without CF or from cross-infection among patients.
In this study the authors intended to identify a possible cross-infection by S. aureus
among patients followed at the CF Centre of Hospital Santa Maria (paediatric group:
68 pts). These patients are already divided into cohorts, in order to minimize cross-
infection by P. aeruginosa, Burkholderia cepacia and MRSA.
Isolates of S. aureus identiﬁed on microbiological exams of sputum or respiratory
secretions, between May 2005 and April 2006, have been studied (144 isolates from
44 patients).
Isolates have been characterized by antibiotic susceptibility tests and pulsed-ﬁeld gel
electrophoresis (PFGE) and the restriction patterns compared by the Bionumerics
computer program. Twenty different clones were identiﬁed. Five of these clones
comprised 65% of the 144 isolates and 25% belonged to the major one.
A tendency for grouping the clones by cohort of patients has been found (Wallace
coefﬁcient 15.3%, conﬁdence interval from 13.9 to 34.9%, not containing the
expected value of 12.9% in the case of independence).
These results suggest that there is cross-infection by S. aureus among patients
with CF.
No relationship, with statistical signiﬁcance, was found between clinical parameters
of disease severity (body mass index, respiratory function tests and hospital
admissions) and any speciﬁc clone (Kruskal-Wallis test).
This study points the necessity to cohort separately patients infected or not with
S. aureus.
